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Abstract  
Geriatric fractures take longer to heal and heal with more complications than those of younger patients; 
however, the mechanistic basis for this difference in healing is not well understood. To improve this 
understanding, we investigated cell and molecular differences in fracture healing between 5 month-old (young 
adult) and 25 month-old (geriatric) mice healing utilizing high-throughput analysis of gene expression. Mice 
underwent bilateral tibial fractures and fracture calluses were harvested at 5, 10, and 20 days post fracture 
(DPF) for analysis. Global gene expression analysis was performed using Affymetrix MoGene 1.0 ST 
microarrays. After normalization, data were compared using ANOVA and evaluated using Principal Component 
Analysis (PCA), CTen, heatmap, and Incromaps analysis. PCA and cross-sectional heatmap analysis 
demonstrated that DPF followed by age had pronounced effects on changes in gene expression. Both un-
fractured and 20 DPF aged mice showed increased expression of immune associated genes (CXCL8, CCL8, and 
CCL5) and at 10 DPF, aged mice showed increased expression of matrix-associated genes, (Matn1, Ucma, 
Scube1, Col9a1, and Col9a3). Cten analysis suggested an enrichment of CD8+ cells and macrophages in old 
mice relative to young adult mice and, conversely, a greater prevalence of mast cells in young adult mice 
relative to old. Finally, consistent with the PCA data, the classic bone healing pathways of BMP, Indian 
Hedgehog, Notch and Wnt clustered according to the time post-fracture first and age second.  
Clinical Significance: Greater understanding of age-dependent molecular changes with healing will help form a 
mechanistic basis for therapies to improve patient outcomes. 
Keywords: Geriatric fracture healing; Bone regeneration; Molecular basis for fracture healing; Microarray; 
inflammation and fracture healing; Mouse model of fracture healing. 
Introduction 
 
When long bone healing proceeds normally, the end result is restoration of normal bone morphology and 
near normal limb function. Failures in bone healing (such as nonunions), however, can result in persistent loss 
of function(1). While delayed unions and non-unions have proven difficult to accurately predict, there are factors 
recognized to increase risk; among them, the currently unmodifiable variable of advanced age, stands out as a 
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particular concern (1,2). Older patients, when they do heal, can heal with insufficient mineral density and are also 
prone to re-fracture(3-5). 
In secondary bone healing, the fracture site is initially filled by a hematoma marked by high levels of 
inflammatory cytokines and infiltrating innate immune cells(6,7). Following establishment of the hematoma, 
mesenchymal progenitors lead to a chondrogenic phase to form a soft callus (8-10), then hypertrophy and 
calcification occurs, (11,12) and, finally, ossification of the soft callus results in a bony callus that is remodeled 
into functional bone(13). Our current understanding of how these processes are altered at cellular and molecular 
levels during geriatric fracture healing are not well-understood. 
Murine models of fracture healing have become a standard method for the assessment of cellular and 
molecular influences on bone repair, and, increasingly, fracture healing models in aged mice have been used to 
better understand alterations and failures in geriatric human populations. Previous gene studies in bone healing 
suggest the molecular complexity of the repair process, with almost 600 known genes and over 100 novel 
genes(14). And while specific elements of classic canonical bone formation pathways such as Wnt/beta-
catenin(15,16) and BMP(17,18) have been studied as a function of aging fracture healing, they have not been 
evaluated together within the context of global gene expression nor have they been well studied in very old 
(rather than moderately aged) mice. Moreover, there has not been a transcriptome-level analysis of fracture 
healing in aged mice.  
Therefore, one of our goals was to characterize the differential dysregulation of classical canonical 
signaling pathways, such as Wnt, BMP and Notch (within an overarching goal of identifying patterns of 
differences for further study), as well as to identify as of yet unknown gene regulatory pathways that 
fundamentally impair healing in our aged fracture model. Based on our previous tissue and cell based 
analysis(19), we expected that very old mice would lag temporally behind young adult mice in the expression of 
genes important for regeneration when compared to young fracture healing. Within that context, we also 
hypothesized that evidence of increase in inhibitory processes, such as sustained inflammation(20,21) would 
characterize the delay in aged fracture healing.  
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Improved understanding of the biological differences in fracture healing between young adult and 
geriatric populations will offer a basis for targeted therapeutic intervention. We have previously characterized 
altered healing patterns in a mouse model of geriatric fracture healing that reflects what is observed in 
humans(19). To further our understanding beyond the tissue and cellular levels and to begin the identification of 
signaling pathways and genetic networks for potential therapeutic manipulation, we have investigated the 
molecular differences between old and young adult fracture healing by characterizing the gene expression 
profile of fracture calluses in young adult and old mice. Better understanding of differential gene expression 
between young and old mice as it relates to the stages of fracture healing will enable more rationally designed 
studies of functionally significant genes and pathways that may explain differences in healing outcomes 
between young and aged cohorts. 
 
Methods 
 
Animal Experimentation and Surgical Model 
All animal procedures were approved by our Institutional Animal Care and Use Committee. 25-month-
old (m/o) C57BL/6 mice represent 50 to 75% survival (hypothesized to be consistent with humans of advanced 
age ) whereas 5 m/o mice represent young adult status; all mice were obtained from the NIH aged rodent colony 
(https://www.nia.nih.gov/research/dab/aged-rodent-colonies-handbook) and underwent transverse bilateral tibial 
fractures as previously described (19,20). Briefly, mice were administered buprenorphine and isoflurane, their legs 
were prepared aseptically, prestabilized with an intramedullary pin (the same sized pin was used for all 
animals), and a traumatic closed fracture was created with a blunt guillotine (three-point bend mechanism). The 
mice were allowed to move freely and given buprenorphine/Nutella ® (Ferrero USA, Inc, Somerset, NJ, USA) 
for 3 additional days and euthanized via CO2 inhalation and cervical dislocation.  
Mouse tibial fractures were gathered at 4 time points (pre-fracture, 5 days post fracture, 10 days post 
fracture, 20 days post fracture) and 2 age groups (5 months old, 25 months old). Five biological replicates, 1 
each from 5 distinct mice, were gathered at each time/age point except for 25 months old, pre-fracture, where 6 
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replicates were gathered. Based on previous fracture and gene expression studies (and in consultation with the 
Microarray Core Facility), we estimated that 5 independent animal samples would provide appropriate power 
for statistical validation of microarray data accounting for variations between animals. In total the experiment 
used 21 mice at 25-months-of-age and 20 mice at 5-months-of-age. Partek genomics suite was used for quality 
control, normalization, comparisons, and analysis.  For the time point 0, we used whole diaphyseal bone 
because no fracture was created and this would provide a baseline gene expression profile against which to 
compare the fracture healing time points. For all subsequent time points, the callus was carefully dissected from 
the remaining bone ends. For RNA extraction, after the mouse was euthanized the samples (either whole bone 
or just callus) were lysed in TriZOL (ThermoFisher, Waltham, MA) then homogenized via tissue tearor, and, 
finally, frozen to release RNA. RNA quality was assed via Agilent Bioanalyzer 2100. 
 
Microarray assay 
Microarray services were provided by the University of Pennsylvania Molecular Profiling Facility, 
including quality control tests of the total RNA samples by Agilent Bioanalyzer and Nanodrop 
spectrophotometry. All protocols were conducted as described in the NuGEN Ovation Pico WTA system v2 
user guide and the Affymetrix GeneChip Expression Analysis Technical Manual. Briefly, 50ng of total RNA 
was converted to first-strand cDNA using reverse transcriptase primed by poly(T) and random oligomers that 
incorporated an RNA priming region. Second-strand cDNA synthesis was followed by ribo-SPIA linear 
amplification of each transcript using an isothermal reaction with RNase, RNA primer and DNA polymerase, 
and the resulting ssDNA was assessed by Bioanalyzer, fragmented and biotinylated by terminal transferase end 
labeling. Five and a half micrograms of labeled cDNA were added to Affymetrix hybridization cocktails, heated 
at 99ºC for 5 min and hybridized for 16 h at 45ºC to Mouse Gene 1.0 ST GeneChips (Affymetrix Inc., Santa 
Clara CA) using the GeneChip Hybridization oven 645.  
The microarrays were then washed at low (6X SSPE) and high (100mM MES, 0.1M NaCl) stringency 
and stained with streptavidin-phycoerythrin. Fluorescence was amplified by adding biotinylated anti-
streptavidin and an additional aliquot of streptavidin-phycoerythrin stain. A GeneChip 3000 7G scanner was 
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used to collect fluorescence signal. Affymetrix Command Console and Expression Console were used to 
quantitate expression levels for targeted genes; default values provided by Affymetrix were applied to all 
analysis parameters. 
Five biological replicates were captured at each time point and age group, with a sixth replicate for 25-
month-old, 0 DPF mice, yielding a total of 41 samples across eight conditions. Affymetrix probe intensities (.cel 
files) were imported into Partek Genomics Suite (v6.6, Partek Inc., St. Louis, MO) were log2-transformed 
expression intensities were calculated with RMA. To correct for batch effects, ComBat(22) was applied. Partek 
was subsequently used to perform an ANOVA analysis on age-DPF interaction, to create comparisons between 
age groups and DPF time points, and to generate of a principal component analysis (PCA). Partek’s 
comparisons are based on two-group “contrast” comparison as part of the ANOVA analysis; this method 
leverages better statistical power in variance estimation versus Student’s t test. Because each tibial sample was 
from a different mouse, comparisons were unpaired.  
 
Top 10 table 
Two group comparison results were ranked by fold-change, taking the top 10 largest magnitude fold-
change genes, across increases and decreases in gene expression, respectively. Genes secondarily required a p-
value less than 0.005 for inclusion on the list. Whereas comparisons across DPF time points yielded many 
statistically significant genes after multiple test correction, comparisons across age within the same DPF time 
point did not always produce significant genes after multiple test correction. For this reason, and due to the 
small sample size and nuanced expression differences between age groups, a fold-change rank based approach 
was taken.  
 
Removal of muscle associated genes 
Due to the sensitivity of RNA-based expression assays to heterogeneous cellular composition, all genes 
associated with muscle tissue were removed from the top 10 tables and heatmaps. The muscle contamination 
gene list was taken from an empirically produced, publicly available gene list from Ayturk et al.(23) Other 
Au
tho
r M
an
us
cri
pt
visualizations (i.e. cell type associated gene heat map, InCroMap visualizations) did not omit muscle 
contamination associated genes as those gene lists were predefined and therefore not subject to change. For 
completeness, the same heatmaps and top 10 tables as shown were also created without removing muscle 
contained associated genes (Supp Fig. 1, Supp. Table 1, and Supp. Table 2).  
 
Heatmap generation 
R was used to visualize heatmaps via the built-in “heatmap” function. The top 5 greatest fold-change genes, 
subject to p<0.005, from each two group comparison, after removing muscle contamination associated genes, 
were used to make a cross-sectional heatmap. Subsequent heatmaps related to signaling pathways and cell type 
markers were also generated via R's heatmap function, but without removal of muscle contamination genes or 
filtered based on p-value (Supp Fig. 1). Signaling and cell type indicator genes were chosen via manual 
curation from the literature.  
 
CTen analysis 
At each time point, genes differentially expressed between young and old mice were loaded into CTen(24) for a 
two group (young vs. old) comparison, requiring p<0.01 in Partek's two group comparison and a fold-change 
greater than 1.3 for inclusion in the gene list. The typical list size used by CTen was between 100-500 genes, 
which is slightly smaller than CTen's reference gene lists. Whereas CTen was designed to derive cell type from 
absolute gene expression values, here it was given differential genes in an effort to deduce which cell types 
were present in different amounts between the two groups. 
 
InCroMap visualization  
Biological pathway figures were generated using InCroMap(25), which images quantitative values overlayed 
atop Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways. Fold-change measures from Partek's two 
group comparisons were used as input to InCroMap's visualization tool. InCroMap's internal pathway statistical 
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significance tool was used to calculate p-values on differential expression within each pathway by selecting 
genes with fold change greater than 1.5 between age groups at each time point. 
 
Results 
 
Fracture callus gene expression patterns clustered by healing time and animal age 
 Principal component analysis (PCA) indicated a cyclical progression of overall gene expression 
following fracture (Fig. 1A). As time post-fracture progressed, differential gene expression was greatest at 10 
days post fracture (DPF) and moved closer to baseline by 20 DPF. The analysis also indicated that gene 
expression clustering was secondarily determined by age of animals. While aged mice show a cyclical 
progression in gene expression similar to young mice, the older mice show greater heterogeneity at day 20 DPF 
with some aged individuals appearing to show a pattern more similar to 10 DPF (Fig. 1A). 
 To further investigate the components governing gene expression during fracture healing, hierarchical 
clustering analysis was performed on the top five most differentially expressed genes from each of time point. 
As with principal component analysis, gene expression clustered initially on DPF and secondarily on animal age 
(Fig. 1B) with 20 DPF clustering closer to 0 DPF relative to 10 DPF. 
 Top ten differentially expressed genes during fracture healing progression were identified using a size-
adjusted step-up p-value of less than 0.005 and then sorted according to fold-change comparing 5 versus 0, 10 
vs 5, and 20 vs 10 DPF in each age group (Table 1). At 5 DPF, there were seven common upregulated genes 
and four common downregulated genes comparing 5-month-old to 25-month-old mice (55% of the top 
regulated genes were common between 5- and 25-month-old mice at day 5). At 10 DPF six genes were 
upregulated in common, and five were downregulated (55% of the top regulated genes are common between 5- 
and 25-month-old mice at day 10), while at 20 DPF, three genes were upregulated in common, and five were in 
common downregulated (40% of the top regulated genes are common between 5- and 25-month-old mice at day 
20). Patterns of expression from 0 to 5, 5 to 10, and 10 to 20 DPF were consistent, regardless of age, with 
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inflammation followed by mesenchymal activation, inflammatory clearing, and then chondrogenesis and bone 
formation.  
10 differentially up-regulated and down-regulated genes for old vs. young mice at each time point post 
fracture were also identified (Table 2). Consistent with PCA and hierarchical clustering analyses, comparisons 
between time points (Table 1) produced greater differential gene expression than did comparisons between age 
groups (Table 2). Both un-fractured and 20 DPF aged mice showed increases in immune associated genes, in 
particular CXCL8, CCL8, and CCL5 were more highly expressed than in 5-month-old mice. At 10 DPF, the 
aged mice show increases in a number of matrix associated genes, in particular Matn1, Ucma, Scube1, Col9a1, 
and Col9a3. Genes that were increased in the 5-month-old mice relative to 25-month-old mice, did not show 
clear patterns, except for increases in Mir99a and Mr15a at day 5, several genes that encode for small nucleolar 
RNAs at days 5, 10, and 20, and a set of Mup genes that are classified as major urinary proteins.  
To examine activation of signal pathways classically relevant to bone formation, target genes 
representing activation of bone morphogenetic protein (BMP), Indian hedgehog (IHH), Notch, and Wnt 
pathways were subjected to hierarchical clustering analysis. As with overall gene expression, clustering of all 
signaling pathways was first on the basis of time post fracture, then by age group (Fig 2). The Notch pathway 
was expressed higher at earlier time points, 0 and 5 DPF, compared to later time points for both young and old 
mice (Fig 2C). The highest level of Wnt and BMP signaling associated genes was at 0 DFP for both young and 
old mice, with moderate expression at 5 and 10 DFP (Fig 2A, D). 
 
Cell type prevalence and proliferation differs based on animal age 
 Differential enrichment of specific cell types between old and young mice at individual time points was 
assessed using CTen (http://www.influenza-x.org/~jshoemaker/cten/)(24). Data were consistent with greater 
prevalence of immune cells in geriatric mice relative to young mice (Fig 3) including the saturation of CD8+ 
cells and macrophages in old mice relative to young mice. Conversely, there was evidence of mast cells in 
young mice relative to old mice. 
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To investigate potential alterations in cell cycle progression during fracture healing in old versus young mice, 
InCroMap was used to visualize cell cycle regulatory genes comparing expression in old and young mice at 
each time point following fracture (Fig. 4). At 0, 5, and 10 DPF, young mice demonstrated higher expression of 
cell cycle progression genes (Fig. 4 A-C). Old mice, however, showed higher expression of cell cycle 
progression genes at 20 DPF (Fig. 4 D).  
 
Discussion 
 
 It is well-accepted that fracture healing in aged patients occurs less robustly than in young individuals 
(19,26)
. The molecular mechanisms underpinning this poor healing, however, are not well defined. In order to 
identify aged-based divergence in the cellular milieu and variations in signaling pathway activation, we 
performed gene expression analyses comparing young adult (5 months) and geriatric (25 months) mice 
throughout the fracture healing process. 
Principal component analysis of global gene expression and hierarchical clustering showed clustering 
primarily on the basis of time post-fracture (Fig 1 A, B) and secondarily on age. Gene expression from aged 
mice at 20 DPF were closer to 10 DPF young adult potentially reflecting the lag in the fracture healing 
morphologically of aged mice compared to young adult. This is graphically represented in Figure 1 where the 
10 day clustering of both ages (in all 3 dimensions) appears to proceed to continued clustering in the young 
cohort (small purple circles) but less so in the aged (large purple) where 2 animals cluster closer to the young 
but 3 cluster closer to the 10 day in the Y, X, and Z axes (1, 2 and 3 animals, respectively). 
Cell Type Enrichment (CTen) analyses(24) indicated that cells of both innate and adaptive immunity were 
more highly enriched in aged mice (Fig 3) throughout the healing process, particularly at 0 DPF and 20 DPF. 
Furthermore, the enrichment of gene expression, in aged mice, approximating that of LPS stimulated 
macrophages is consistent with an underlying basal inflammatory state often associated with aging. Similarly, in 
aged 20 DPF fractures, we detected enrichment of CD8+ T cells, which has been shown to negatively impact 
bone regeneration (21,27). We also found differential immunological pathway activation between age groups at 0 
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DPF and 20 DPF, which further supports the difference in activity of immune cells between young adult and old 
mice (Supp Table 3). Conversely, we found mast cells, which have been identified as necessary for proper 
bone healing, were enriched in young adult fractures at the midpoint of the healing process (10 DPF)(28-30) but 
not in aged fracture healing. Taken together, these cell type enrichment data suggest an “immune” cellular 
environment that represses healing in the aged mice relative to the young adult mice.  
Examination of individual genes during the fracture healing process further supported a basal pro-
inflammatory state and an increased variation in bone formation in aged mice. Prior to fracture and late in the 
fracture healing process, aged mice demonstrated higher expression of the proinflammatory cytokine CCL8, the 
T cell chemoattractant CXCL9, and the T cell-secreted cytokine CCL5 (Table 2) (31-33). Aged mice showed 
decreased expression of Matrix Extracellular Phosphoglycoprotein (MEPE), which is a component of 
mineralizing bone matrix and Ephrin receptor A4 (Epha4), which has been implicated in osteoblast maturation 
(Table 2) (34,35). Furthermore, aged mice show lower 5 DPF expression of Mir-15a (Table 2), whose pathologic 
decreased expression in Myasthenia Gravis has been shown to promote proinflammatory cytokines production 
(36)
. Finally, Mup1, a regulator for glucose and lipid metabolism in mice (37,38), and other Mup genes are down 
regulated at 10 DPF in aged mice, possibly to conserve energy to promote fracture healing (Table 2). 
We also analyzed classic canonical signaling pathways (BMP, Wnt, Notch, Hedgehog) that are known 
to be important to both bone formation and healing. Clustering of signaling pathways demonstrated that days 
post-fracture followed by age were drivers of differential gene expression (Fig 2). The higher earlier levels of 
Notch signaling in old and young adult fractures which decreases with time may suggest that sustaining 
signaling could better sustain the proliferative stages of healing. In combination with our previous study which 
indicated that low basal-levels of Notch signaling in mesenchymal progenitor cells of geriatric mice were still 
inducible(19), these results support the further investigation of the Notch pathway as a therapeutic target. On the 
other hand, the lack of substantial age-based differential relative expression in classical osteogenic pathways 
suggests that investigation of potential therapeutic targets for improving age-associated fracture healing should 
be expanded.  
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Finally, we compared the expression levels of cell cycle regulatory genes. Minimal differences are 
observed in the unfractured bone at 0 DPF (Fig 4A). At 5 DPF, however, there was an increased activation of 
cell cycle genes in young adult mice in comparison to old mice (Fig 4B). By 20 DPF, there was an increase in 
activation of cell cycle genes in geriatric mice (Fig 4D). These data suggest that old mice, while capable of 
initiating regeneration, lag behind young adult mice during the fracture healing process, in part secondary to 
sustained inflammation and delayed cell proliferation.  
The primary goal of this study was to probe the cellular and molecular basis for our previous 
observation of reduced magnitude of tissue-based aged healing(19). Therefore, our study focused on microarray 
gene expression analysis patterns. While our data demonstrated that the fundamental molecular machinery and 
pathways governing the bone healing process are not lost with advanced age, underlying immune dysfunction 
and delayed cellular proliferation likely contribute to the substantially reduced capacity to heal observed with 
age. Future experiments will explore the function importance of changes in the activation of specific pathways 
and critical genes within them.  
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Figure Legends 
 
Fig. 1 Principle component and hierarchical clustering analysis of gene expression. (A) Principal 
component analysis indicates a cyclical progression of gene expression during fracture healing. As time 
Au
tho
r M
an
us
cri
pt
progresses, differential gene expression is greatest at 10 days and moves closer to baseline by 20 days. Gene 
expression profiles clustered primarily on the basis of DPF, then by age. (B) Hierarchal clustering analysis of 
top 5 most differentially expressed genes at each DPF. Gene expression clustered initially on days post fracture 
and secondarily on animal age. Red indicates higher level of expression, whereas green indicates lower level of 
expression. 
 
Fig. 2. Hierarchical clustering of signal pathway target genes. Analysis of (A) BMP, (B) IHH, (C) Notch, 
and (D) Wnt target genes cluster first on the basis of time post fracture, then by age group.  
 
Fig. 3. Cell Type Enrichment (CTen) analysis of gene expression. Differential enrichment of specific cell 
types between old and young adult mice at individual time points was assessed using CTen. Aged mice showed 
a greater tendency towards CD8+ T cell and activated macrophage enrichment, where younger cells showed a 
greater tendency towards mast cell and osteoblast enrichment. 
 
Fig. 4. Cell cycle marker gene expression analysis. InCroMap was used to visualize cell cycle regulatory 
genes comparing expression in old and young adult mice at (A) 0, (B) 5, (C) 10, and (D) 20DPF. Green 
represents higher expression in young adult mice, whereas red indicates higher expression in old mice. At 0, 5, 
and 10 DPF, young adult mice demonstrated higher expression of cell cycle progression genes. Old mice 
showed higher expression of cell cycle progression genes at 20 DPF. 
 
Supplemental Figure 1. Hierarchal clustering analysis of top 5 most differentially expressed genes at each DPF 
with the muscle cells included. Gene expression clustered initially on days post fracture and secondarily on 
animal age. Red indicates higher level of expression, whereas green indicates lower level of expression.  
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Table 1: Top ten up- and down-regulated genes during fracture healing between time points post 
fracture.  
 
5DPF vs Unfractured   10DPF vs 5 DPF
 5-Months Old   25-Months Old   5-Months Old 
 
Gene 
Name 
Fold 
Change q-value   
Gene 
Name 
Fold 
Change q-value   
Gene 
Name 
Fold 
Chang
e 
q-value 
Ccl8 51.7068 5.46E-13   Timp1 16.319 8.89E-12   Clec3a 
32.846
8 2.10E-07 
Ccl7 23.0152 2.70E-10   Tnfaip6 15.7304 1.02E-10   
Col10a
1 
25.577
9 2.87E-09 
Timp1 19.4469 1.83E-12   Ccl7 15.6649 3.29E-09   Matn3 
11.342
4 1.12E-06 
Serpine
1 18.7733 
8.26E-
13   Prg4 14.4678 2.87E-08   Lect1 
11.274
2 2.19E-07 
Tnfaip6 18.532 3.26E-11   
Serpine
1 14.4383 8.89E-12   Scrg1 
11.169
5 4.76E-06 
Sfrp1 18.0681 4.70E-10   Cthrc1 14.1115 2.96E-09   Hapln1 
10.894
3 5.57E-05 
Saa3 17.6519 1.26E-10   Vcan 13.6722 8.89E-12   Zim1 
7.1408
4 2.87E-09 
Ms4a6d 17.2707 1.44E-11   Ccl8 12.3968 9.52E-10   Agtr2 6.4351 4.05E-06 
Cxcl5 17.0611 2.31E-08   Sfrp1 11.2241 1.35E-08   Chad 
6.3548
6 
0.00032180
3 
Upregulated 
Genes 
Ccl12 16.0445 5.79E-13   Saa3 10.7828 4.84E-09   Lipi 
6.1996
5 9.35E-09 
     
 
      
Gypa -36.7476 1.16E-06   Ear1 
-
20.2929 7.23E-07   Cxcl5 -14.468 9.92E-07 
Rhag -31.0394 1.28E-06   Ear6 
-
14.6878 1.02E-07   Arg1 -10.049 2.87E-09 
Car1 -29.982 1.07E-06   Vpreb1 
-
11.9426 1.62E-09   Saa3 -9.149 3.36E-07 
Cldn13 -24.9896 2.09E-07   Prg2 
-
11.7774 2.52E-06   Cxcl2 -8.7526 4.17E-05 
Car2 -22.3932 1.11E-07   Vpreb3 
-
11.4993 1.05E-09   Prg4 -8.4259 1.39E-05 
Ctse -22.3846 9.61E-07   Ly6g 
-
10.0661 1.36E-05   Il1rl1 -6.0817 2.03E-06 
Kel -21.8589 1.50E-07   Rhag 
-
9.62421 
0.0003333
38   Il6 -5.8171 
0.00024932
8 
Rhd -21.5165 3.67E-07   Igk-V1 
-
9.49088 1.30E-05   Ccl2 -5.6197 1.30E-05 
Ly6g -20.394 2.50E-07   Mcpt8 
-
8.78738 9.34E-08   
Ms4a4
a 
-4.8786 2.05E-07 
Downregulate
d Genes 
Ear1 -20.3285 8.70E-07   Gypa 
-
8.77516 
0.0008378
6   Cd163 -4.8702 4.33E-06 
Bold genes are present in both 5 and 25 month         
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25-month vs 5 month 
 Unfractured 5 Days Post Fracture 10 Days Post Fracture
 Gene Name Fold Change p-value 
Gene 
Name 
Fold 
Change p-value Gene Name
Cxcl9 3.9176 0.0003 Igj 3.88103 0.0006 
  
  
  
Ucma 
Ccl8 3.82189 1.99E-06 Amy1 3.54147 1.56E-05   Mia1 
Ubd 3.54092 4.31E-05 Tspan8 2.92372 0.0019 3110079O15Rik
Ccl5 2.98618 0.0007 Krt18 2.89207 6.70E-05 
  
  Scube1
Csprs 2.61911 3.39E-08 
  
  
  
  
  
  
  
Nrap 2.74706 0.0022   Col9a1
Rtp4 2.55427 6.54E-05 Camk2b 2.63232 8.52E-06 Moxd1 
Oasl2 2.52529 6.00E-05 Cmya5 2.62953 0.0013 Col9a3
Gm7609 2.50707 6.22E-08 
  
  
  Trdn 2.56702 0.0049 
  
  
  Matn1 
Nlrc5 2.4735 4.46E-06 Fsd2 2.53774 0.001 Cspg4 
Higher 
Expression 
at 25-
Months 
Gm7609 2.45712 2.48E-08 Gm10674 2.51765 0.0015 Mfge8 
    
  
  
   
  
  
 
Adamts3 -1.66205 0.001 Mir99a -3.10473 0.0003 Mup7 
Rag2 -1.62362 0.0003 Snora73a -3.06453 0.0002 Mup11 
Mepe -1.59314 0.004 
  
  
  Snora73b -3.03144 0.0002 
  
  
  Mup19 
Zfp521 -1.51664 0.004 Snora44 -2.74157 0.001 Mup2 
Eif2b3 -1.40897 0.0002 Crabp1 -2.69092 1.55E-05 Mup1 
2310047B19Rik -1.3452 0.0006 Npm3 -2.04601 1.56E-05 
  
  
  Snord118
2700097O09Rik -1.33643 0.0032 Fcrls -2.03889 2.11E-05 Adipoq 
Etv1 -1.33367 0.0001 Mir15a -1.99839 0.0029 
  
  Mcpt4 
Epha4 -1.31656 0.0022 
  
  
  
  
  
  
Mir15a -1.98857 0.0002   Snora23
Lower 
Expression 
at 25-
Months 
Mrpl21 -1.28749 0.0005   Arsi -1.92852 0.0007   Vpreb1
 
 
 
 
 
 
 
 
 
Table 2: Top 10 up- and down-regulated between old versus young mice at each time point post-fracture.  
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Figure 1 
 
Figure 2 
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Figure 3 
 
Figure 4 
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Figure 5 
 
 
 
 
 
